Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It has been used for decades to treat these conditions, but like all medications, there is a risk of overdose. In this article, we will discuss the dangers of clonidine overdose, how to recognize the signs and symptoms, and how to avoid it.
Clonidine is a prescription medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. It is a central alpha-2 agonist that works by decreasing the activity of the sympathetic nervous system, which regulates blood pressure and heart rate. It is usually taken as a pill, but can also be taken as a patch or liquid.
Clonidine overdose can be dangerous and even fatal. Signs and symptoms of a clonidine overdose may include: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression. In severe cases, an overdose can lead to coma and death.
It is important to be aware of the signs and symptoms of a clonidine overdose. If you or someone you know is taking clonidine and is exhibiting any of the following symptoms, seek medical attention immediately: confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
The best way to avoid a clonidine overdose is to take the medication as prescribed by your doctor. Do not take more than the recommended dose and do not take it more often than prescribed.
Clonidine is a medication used to treat high blood pressure, Attention Deficit Hyperactivity Disorder (ADHD), and anxiety disorders. While it is effective in treating these conditions, there is a risk of overdose. The dangers of clonidine overdose include confusion, dizziness, drowsiness, dry mouth, nausea, vomiting, constipation, weakness, low blood pressure, slow heart rate, and respiratory depression.
1.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
2.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
3.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
4.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
5.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
1.
How EPCORITAMAB is Revolutionizing the Treatment of Cancer
2.
Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers
3.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
4.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation